Skip to main content
Equibles

OPPENHEIMER & CO INC

Position in INAB — In8bio, Inc.

CIK 822581 NEW YORK, NY
Back to INAB Full portfolio

Position in INAB

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$88,889
+$53,321 QoQ
Shares Held
63,042
+162.3% QoQ
Ownership
0.639%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 21 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

OPPENHEIMER & CO INC holds $50,552,262 across 50 Biotechnology names. INAB ranks #42 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 22,129 $13,798,316
2 VKTX
Viking Therapeutics, Inc.
 146,259 $5,705,563
3 RVMD
Revolution Medicines, Inc.
 15,400 $2,884,112
4 TYRA
Tyra Biosciences, Inc.
 83,783 $2,676,029
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,250 $2,111,102
6 TRVI
Trevi Therapeutics, Inc.
 99,771 $1,860,729
7 CAPR
Capricor Therapeutics, Inc.
 75,714 $1,823,193
8 NTLA
Intellia Therapeutics, Inc.
 107,453 $1,818,104

All Filings in INAB

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $88,889 63,042
2026-03-31 $35,568 24,033